Description
CEP-28122 is an ALK inhibitor. It inhibits tumor growth in ALK positive anaplastic large-cell lymphoma (ALCL), non-small cell lung cancer (NSCLC), and neuroglastoma cells.
| Product Unit Size | Cost | Quantity | Stock |
|---|
CEP-28122 is an ALK inhibitor. It inhibits tumor growth in ALK positive anaplastic large-cell lymphoma (ALCL), non-small cell lung cancer (NSCLC), and neuroglastoma cells.
| Cas No. | 1354545-57-5 |
|---|---|
| Purity | ≥98% |
| Formula | C28H35ClN6O3 • CH4O3S |
| Formula Wt. | 635.18 |
| IUPAC Name | (1S,2S,3R,4R)-3-[(5-Chloro-2-{[(7S)-1-methoxy-7-(4-morpholinyl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl]amino}-4-pyrimidinyl)amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide methanesulfonate (1:1) |
| Synonym | CEP 28122 Mesylate, CEP28122 Mesylate |
| Solubility | 10 mM in DMSO |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Cheng M., Quail M., et al. CEP-28122, a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase with antitumor activity in experimental models of human cancers. Mol Cancer Ther. 11(3):670-79 (2012). PMID: 22203728.
CDK9 inhibitor.
SGLT2 inhibitor
Anthracycline, DNA intercalator; topoisomerase ...
Aldose reductase inhibitor.
Allosteric inhibitor
BHA derivative; potential Ca2+ ATPase inhibitor...
Oxidative phosphorylation inhibitor.
Endogenous peptide hormone, involved in stress ...
Triazole; 14-α demethylase inhibitor, potentia...
Benzophenanthridine alkaloid found in various p...
TRPA1 agonist, xanthine oxidase inhibitor.
Major metabolite of ginsenosides Rb1, Rb2, Rc, ...
Fungistatic
Aminoglycoside; protein translation inhibitor, ...
Dihydropyridine; L-type Ca2+ channel blocker.
β1-adrenergic antagonist.
mAChR agonist, selective for M2.
Semi-synthetic diterpene originally found in Ta...
AT1 antagonist.
Triterpenoid found in Centella.